Mishima-gun, Japan

Tsuneyuki Sugiura



Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Osaka, JP (2000 - 2003)
  • Mishima-gun, JP (2001 - 2005)

Company Filing History:


Years Active: 2000-2005

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tsuneyuki Sugiura

Introduction: Tsuneyuki Sugiura, a renowned inventor based in Mishima-gun, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of seven patents, Sugiura is recognized for his innovative work in developing compounds aimed at treating various diseases.

Latest Patents: Among his latest patents is a groundbreaking formulation of aminobutyric acid derivatives, which serve as active ingredients in pharmaceutical compositions. These derivatives, defined by specific chemical structures in the patent specifications, have shown promise in inhibiting matrix metalloproteinase. As a result, they are useful in the prevention and treatment of a spectrum of diseases, including rheumatoid diseases, osteoarthritis, osteoporosis, and various other serious health conditions such as multiple sclerosis and acute myocardial infarction.

Career Highlights: Throughout his career, Tsuneyuki Sugiura has been associated with prominent companies in the pharmaceutical industry. Notably, he has worked with Ono Pharmaceutical Co., Ltd., where his research and innovations have made a considerable impact in the development of effective therapeutic agents.

Collaborations: Sugiura's work has also involved collaboration with notable colleagues such as Kanji Takahashi and Katsuhito Sakaki. These partnerships have helped advance his research and further the development of his patented compounds.

Conclusion: Tsuneyuki Sugiura's innovative spirit and dedication to research are evident in his extensive patent portfolio. His contributions, particularly in pharmaceuticals, underscore the vital role of inventors in advancing healthcare solutions and improving patient outcomes. As he continues to explore new avenues for innovation, the medical community eagerly anticipates his future discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…